Assessment of cardiovascular risk and choice of antihypertensive therapy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Internal Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11906-004-0052-2.pdf
Reference39 articles.
1. Chobanian AV, Bakris GL, Black HR, et al.: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003, 289:2560–2572. These are the current US national guidelines for prevention and management of hypertension. The report emphasizes that systolic blood pressure is more important than diastolic; asserts that there is an incremental increase in CVD risk extending down into what was formerly regarded as the normal range of blood pressure, defining a prehypertensive blood pressure; and implies that thiazide diuretics should be used for most patients.
2. NCEP Expert Panel: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP): expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486–2497.
3. Laurent S: Guidelines from the British Hypertension Society: the lower the blood pressure the better. BMJ 2004, 328:593–594.
4. Williams B, Poulter NR, Brown MJ, et al.: Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society. 2004-BHS IV. J Hum Hypertens 2004, 18:139–185. These are current British guidelines for management of high blood pressure. They underscore that the chief determinant of the benefit of blood pressure lowering is the level of blood pressure achieved rather than choice of therapy, recommend use of at least two antihypertensive drugs in most patients, and assert that these should be combinations of drugs with different modes of action.
5. Wilson PWF, D’Agostino RB, Levy D, et al.: Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837–1847. Report from the Framingham Study proposing a CHD risk prediction score with risk factor categories.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prediction of Prehypertenison and Hypertension Based on Anthropometry, Blood Parameters, and Spirometry;International Journal of Environmental Research and Public Health;2018-11-16
2. The Effects of Aqueous Extract from Nardostachys chinensis Batalin on Blood Pressure and Cardiac Hypertrophy in Two-Kidney One-Clip Hypertensive Rats;Evidence-Based Complementary and Alternative Medicine;2017
3. Individualization of Antihypertensive Drug Treatment;Diabetes Care;2013-07-17
4. Vasorelaxant effects of the extracts and some flavonoids from the buds ofCoreopsis tinctoria;Pharmaceutical Biology;2013-06-13
5. High prevalence of peripheral arterial disease in hypertensive patients;Journal of Hypertension;2012-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3